Board Meetings
| Company | Meeting | Agenda | Details | Listed |
|---|---|---|---|---|
Financial Results | To consider and approve the financial results for the period ended September 30, 2026 | |||
Financial Results | To consider and approve the financial results for the period ended September 30, 2026 | |||
Financial Results | To consider and approve the financial results for the period ended September 30, 2026 | |||
Financial ResultsOther Business | To consider and approve the Unaudited financial results for the quarter and half year ended September 30, 2026 and other business matters | |||
Financial Results | To consider and approve the financial results for the period ended September 30, 2026 | |||
Financial ResultsDividend | To consider and approve the financial results for the period ended September 30, 2026 and interim dividend, if any. | |||
Fund RaisingOther Business | Mangalam Global Enterprise Limited has informed that the meeting of the Management Committee of the Board of Directors of the Company is scheduled to be held on Friday, 16 October 2026, inter alia, to consider and approve the issuance of Non-Convertible Debentures aggregating up to Rupees 150 Crores and other Business. | |||
Financial Results | To consider and approve the financial results for the period ended September 30, 2026 | |||
Financial ResultsDividend | To consider and approve the unaudited financial results for the period ended September 30, 2026 and 2nd interim dividend | |||
Financial Results | To consider and approve the financial results for the period ended September 30, 2026 | |||
Financial ResultsOther Business | To consider and approve the financial results for the period ended September 30, 2026 and other business matters | |||
Financial Results | To consider and approve the financial results for the period ended September 30, 2026 | |||
Financial Results | To consider and approve the financial results for the period ended September 30, 2026 | |||
Financial Results | To consider and approve the Unaudited Financial Results(Standalone and Consolidated) of the Company for the quarter and half year ended September 30, 2026. | |||
Financial ResultsOther Business | To consider and approve the financial results for the period ended September 30, 2026 and other business matters | |||
Financial Results | Solara Active Pharma Sciences Ltd has informed the exchange that the meeting of the Board of Directors of the Company is scheduled to be held on Friday, October 16, 2026 ,inter alia, to consider and approve the unaudited Standalone and Consolidated financial results of the Company for the quarter and half year ended September 30, 2026. | |||
Financial Results | To consider and approve the financial results for the quarter ended September 30, 2026 | |||
Financial ResultsOther Business | To consider and approve the financial results for the period ended September 30, 2026 and other business matters | |||
Financial Results | To consider and approve the financial results for the period ended September 30, 2026 | |||
Fund Raising | To consider fund raising by issue of equity shares of the Bank on preferential basis. | |||
Financial Results | To consider and approve the unaudited standalone and consolidated financial results of the Company for the quarter and half year ended September 30, 2026. | |||
Fund Raising | To consider Fund Raising | |||
Financial Results | To consider and approve the financial results for the period ended September 30, 2026 | |||
Financial Results | To consider and approve the un-audited financial results for the quarter and half year ended September 30, 2026 | |||
Financial Results | To consider and approve the financial results for the period ended September 30, 2026 | |||
Financial Results | To consider and approve the unaudited standalone and consolidated financial results of the Bank for the quarter/half-year ending September 30, 2026 | |||
Financial Results | To inter alia consider and approve the unaudited financial results (standalone and consolidated) for the quarter and six months ending September 30, 2026. | |||
Financial Results | To consider and approve the financial results for the period ended September 30, 2026 | |||
Financial Results | To consider and approve the financial results for the period ended September 30, 2026 | |||
Fund Raising | To consider and discuss the Matter of Fund Raising through Right Issue | |||
Financial ResultsOther Business | To consider and approve the financial results for the period ended September 30, 2026 and other business matters | |||
Financial Results | To consider and approve the financial results for the period ended September 30, 2026 | |||
Financial Results | To consider and approve the financial results for the quarter and half year ended September 30, 2026 | |||
Financial Results | To consider and approve the financial results for the period ended September 30, 2026 | |||
Financial Results | To consider and approve the financial results for the period ended September 30, 2026 | |||
Financial Results | Rossari Biotech Ltd has informed NSE that the meeting of the Board of Directors of the Company is scheduled on 17/10/2026 ,inter alia, to consider and approve Unaudited Financial Results (Standalone & Consolidated) for the quarter and half year ended September 30, 2026. | |||
Financial ResultsOther Business | To consider and approve the financial results for the period ended September 30, 2026 and other business matters | |||
Financial Results | Intimation of the date of the Board Meeting for considering Un-audited Financial Results for the Quarter (Q2) and Half Year ended September 30, 2026 | |||
Financial ResultsOther Business | To consider and approve the unaudited financial results for the quarter ended June 30, 2026 and other business matters | |||
Financial Results | To consider and approve the financial results for the period ended September 30, 2026 | |||
Financial Results | To consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026 | |||
Financial ResultsDividend | To consider and approve the financial results for the period ended September 30, 2026 and dividend | |||
Financial Results | To consider and approve the financial results for the quarter and half year ended September 30, 2026 | |||
Financial Results | To consider and approve the financial results for the period ended Jun 30, 2026 | |||
Other Business | To consider other business matters | |||
Financial ResultsOther Business | To consider and approve the financial results for the period ended September 30, 2026 and other business matters | |||
Financial Results | To consider and approve the financial results for the period ended September 30, 2026 | |||
Financial Results | To consider and approve the financial results for the period ended September 30, 2026 | |||
Financial Results | To consider and approve the financial results for the period ended September 30, 2026 | |||
Financial Results | To consider and approve the audited financial results (Standalone & Consolidated) and audited financial statements (Standalone & Consolidated) of the Company for the quarter and half year ended September 30, 2026. |
Board meetings explained
What is a board meeting intimation?
Does a scheduled board meeting mean the decision will happen?
How far in advance are board meetings announced?
Can a company change or cancel the meeting date?
Why does one meeting show several agenda items?
What does "Other business matters" mean?
How is this different from the corporate actions calendar?
What does the "Listed" date mean?
How often is this calendar updated?
About this calendar
This page tracks board meetings that NSE listed companies have intimated to the exchange in advance — the meeting date, and what the board has said it will consider. Agendas include quarterly and annual financial results, fund raising, dividends, buybacks, bonus issues, stock splits, voluntary delisting, and general business. Where a company has filed a description of the business to be transacted, it is shown in its own words rather than summarised.
A scheduled meeting is a plan, not an outcome. A board that meets to consider fund raising may approve it, change it or decide against it, and companies do reschedule their own meetings. Once a decision is taken and carries an ex-date, it appears on the corporate actions calendar instead. Filter by date range or agenda, search for a company by name or symbol, or sign in to narrow the calendar to your own watchlist or portfolio.